Bloomington, Ind., July 21, 2011 – Cook Medical invites urologists to contribute to the Resonance® Metallic Ureteral Stent Registry. The registry is designed to allow physicians the opportunity to establish best practices and collect information regarding patient outcomes following the use of the Resonance Stent. Physicians who participate in the registry will also have access to aggregated information, making the transparent system beneficial to both clinical and industry interests.
The registry is built on Cook’s exclusive online system called OpenDoor℠ — the industry’s first transparent clinical-data management offering for physicians. OpenDoor provides users with the opportunity to review clinical data, benchmark individual results and collaborate with physicians to identify better methods of providing patient care. Physicians and researchers will be able to track outcomes and view community trends within 30 days of entering information. The Resonance registry will also provide a means to collaborate globally across multiple medical specialties, institutions, societies and agencies to evaluate quality patient data.
“We are excited about the registry and pleased to make it available to urologists working with the Resonance Metallic Ureteral stent,” said Jean-Marc Criessel, global leader of Cook’s Urology business unit. “This kind of physician and industry collaboration is what leads to innovative medical products and improved patient care.”
To learn more about the Resonance Registry and how to participate, please contact Corrie Threlkeld at 812.339.2235 ext. 7327 or corrie.threlkeld@cookmedical.com.
About the Resonance Metallic Ureteral Stent
When part of the urinary system becomes blocked by a benign obstruction, the kidneys are unable to drain properly. The Cook Resonance Metallic Ureteral Stent’s unique design relieves this blockage, allows a patient’s urinary system to drain normally and can reduce the frequency of stent changes or the need for debilitating nephrostomy tubes. The stent’s superior compressive and radial strength can withstand up to 25 times more extrinsic compression than plastic stents¹, enabling it to remain patent for up to 12 months.
About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter @cookmedicalpr and @CookUro.